Pharma major Ranbaxy has voluntarily recalled its entire lot of ‘Nitrofurantoin’100 mg capsules from the US retail market. The move is on account of the capsules not meeting the US drug manufacturing standards. The drug is an antibiotic commonly used to treat urinary tract infection. It must be noted that the company in November last year had recalled ‘Gabapentin’ tablets after the impurities content in the drug exceeded the permissible limits. Though the US sales for the drug are not significant, this development could affect the long term performance of the company especially in light of the fact that it is already facing trouble with the US FDA, which has shut the company’s manufacturing plants at Poanta Sahib and Dewas. Sell on every rise.....CMP 169
No comments:
Post a Comment